NORDIC NANOVECTOR TO HOST CAPITAL MARKETS DAY IN OSLO ON 22 NOVEMBER 2017
Oslo, Norway, 14 August 2017 Nordic Nanovector ASA (OSE: NANO), a biopharmaceutical company focusing on the development and commercialisation of novel targeted therapeutics forhaematological cancers, will host a capital markets day on 22 November 2017. The date has been changed from 27 September due to availability of speakers. The capital markets day presentations will follow immediately after the third quarter 2017 earnings presentation. Members of the company’s executive management team and external speakers will share insights on Nordic Nanovector's strategy and market